COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi's Tzield receives US FDA approval as first disease-modifying therapy for stage 3 type 1 diabetes, targeting autoimmune attack against insulin-producing beta cells -
COMMUNIQUÉ DE PRESSE
BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
BioNxt Solutions Inc. announces non-brokered private placement of units at $0.33 per Unit with maximum gross proceeds of $2,000,000. Offering includes common shares and purchase warrants -
-
COMMUNIQUÉ DE PRESSE
Fox River Provides Reminder To Vote And Updated Dissent Rights
Fox River's special meeting for Securityholders to consider an Arrangement Resolution with Avenir Minerals Limited. Shareholders offered $1.10 per Common Share in cash. Voting instructions and reasons provided for the recommendation -
COMMUNIQUÉ DE PRESSE
Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing
Inventiva repays EIB loans, repurchases warrants, and issues new debt financing. Completes key steps in Combined Transaction. Details on Tranche A/B Convertible Bonds and Tranche B Amortized Bonds. Company focused on MASH treatment -
COMMUNIQUÉ DE PRESSE
Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le cadre du Nouveau Financement
Inventiva rembourse les prêts BEI, rachète des BSA BEI et émet des obligations dans un nouveau financement. Opération clé pour le traitement de la stéatohépatite. Détails ci-dessous -
-
-
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
